Lars Wilde - Compass Pathways Senior Advisor
| CMPS Stock | USD 3.49 0.08 2.35% |
Executive
Lars Wilde is Senior Advisor of Compass Pathways Plc
| Age | 39 |
| Address | 33 Broadwick Street, London, United Kingdom, W1F 0DQ |
| Phone | 44 71 6676 6461 |
| Web | https://compasspathways.com |
Compass Pathways Management Efficiency
The company has return on total asset (ROA) of (0.3522) % which means that it has lost $0.3522 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6468) %, meaning that it created substantial loss on money invested by shareholders. Compass Pathways' management efficiency ratios could be used to measure how well Compass Pathways manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.41 in 2025. Return On Capital Employed is likely to drop to -0.5 in 2025. At this time, Compass Pathways' Non Current Assets Total are comparatively stable compared to the past year. Non Currrent Assets Other is likely to gain to about 7.4 M in 2025, whereas Net Tangible Assets are likely to drop slightly above 135.8 M in 2025.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Chad JD | The Ensign Group | 47 | |
| Diane Kumarich | Addus HomeCare | N/A | |
| Mandy Hale | DaVita HealthCare Partners | N/A | |
| Tim Stewart | Addus HomeCare | N/A | |
| Jennifer JD | Surgery Partners | 54 | |
| Isa Diaz | Acadia Healthcare | N/A | |
| Roxanne Womack | Surgery Partners | N/A | |
| BSN MBA | DaVita HealthCare Partners | N/A | |
| James Hearty | DaVita HealthCare Partners | 56 | |
| Nasser MD | Acadia Healthcare | 46 | |
| Jessica Hergenreter | DaVita HealthCare Partners | N/A | |
| Dylan Black | Enhabit | 56 | |
| FACP MD | InnovAge Holding Corp | 57 | |
| Brian Monahan | Addus HomeCare | N/A | |
| Michael Wattenbarger | Addus HomeCare | 54 | |
| Jason Anderson | US Physicalrapy | N/A | |
| Nicole DAmato | InnovAge Holding Corp | 46 | |
| Mark Palmenter | Acadia Healthcare | N/A | |
| III CPA | Cross Country Healthcare | 53 | |
| Leland Thomas | agilon health | N/A | |
| Ryan Solomon | Enhabit | N/A | |
Management Performance
| Return On Equity | -0.65 | ||||
| Return On Asset | -0.35 |
Compass Pathways Plc Leadership Team
Elected by the shareholders, the Compass Pathways' board of directors comprises two types of representatives: Compass Pathways inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Compass. The board's role is to monitor Compass Pathways' management team and ensure that shareholders' interests are well served. Compass Pathways' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Compass Pathways' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Teri MBA, Principal CFO | ||
| Guy Goodwin, Chief Officer | ||
| Trevor Mill, Chief Officer | ||
| Christopher Williams, Chief Officer | ||
| MBA MA, Chief Officer | ||
| Anne Benedict, Chief Officer | ||
| Ekaterina MD, CoFounder Director | ||
| Lars Wilde, Senior Advisor | ||
| Susan Stansfield, Advisor | ||
| George Goldsmith, Chairman Cofounder | ||
| Michael Falvey, Chief Officer | ||
| MaryRose Hughes, Principal CFO | ||
| Greg Ryslik, Engineering, AI | ||
| Stephen Schultz, Senior Relations | ||
| Matthew Owens, General Officer | ||
| MSc MD, Chief Officer |
Compass Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Compass Pathways a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.65 | ||||
| Return On Asset | -0.35 | ||||
| Current Valuation | 148.2 M | ||||
| Shares Outstanding | 92.44 M | ||||
| Shares Owned By Insiders | 16.39 % | ||||
| Shares Owned By Institutions | 35.86 % | ||||
| Number Of Shares Shorted | 3.89 M | ||||
| Price To Book | 1.67 X | ||||
| EBITDA | (123.8 M) | ||||
| Net Income | (118.46 M) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Compass Stock Analysis
When running Compass Pathways' price analysis, check to measure Compass Pathways' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Compass Pathways is operating at the current time. Most of Compass Pathways' value examination focuses on studying past and present price action to predict the probability of Compass Pathways' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Compass Pathways' price. Additionally, you may evaluate how the addition of Compass Pathways to your portfolios can decrease your overall portfolio volatility.